Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Jua Choi"'
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
HLA (Human Leucocyte Antigen) sensitization is a significant barrier to successful kidney transplantation. It often translates into difficult crossmatch before transplant and increased risk of acute and chronic antibody mediated rejection after trans
Externí odkaz:
https://doaj.org/article/330dd304bdc2425caa4377bb3781c8f5
Autor:
Mieko Toyoda, Bong-Ha Shin, Shili Ge, James Mirocha, David Thomas, Maggie Chu, Edgar Rodriguez, Christine Chao, Anna Petrosyan, Odette A. Galera, Ashley Vo, Jua Choi, Alice Peng, Joseph Kahwaji, Stanley C. Jordan
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
Viral infections represent significant morbidity and mortality factors in kidney transplant recipients, with CMV, EBV, and BKV infections being most common. Desensitization (DES) with IVIg and rituximab with/without plasma exchange followed by kidney
Externí odkaz:
https://doaj.org/article/cbc2aab3a00b48aea14fd09dfaf2f47c
Autor:
Stanley C. Jordan, Noriko Ammerman, Jua Choi, Edmund Huang, Reiad Najjar, Alice Peng, Supreet Sethi, Rana Sandhu, Janet Atienza, Mieko Toyoda, Shili Ge, Kathlyn Lim, Matthew Gillespie, Xiaohai Zhang, Mark Haas, Ashley Vo
Publikováno v:
Kidney International Reports. 7:720-731
Interleukin-6 (IL-6) is an important mediator of inflammation and activation of T cells, B cells, and plasma cells. Excessive IL-6 production is linked to human diseases characterized by unregulated antibody production, including alloimmunity, where
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6374cd679913a9a54c9efa06fddeb593
https://doi.org/10.1016/j.ekir.2022.01.1074
https://doi.org/10.1016/j.ekir.2022.01.1074
Autor:
Helen Pizzo, James Mirocha, Jua Choi, Jonathan Garrison, Mark Haas, Xiaohai Zhang, Elaine S. Kamil, Irene Kim, Stanley C. Jordan, Dechu P. Puliyanda
Publikováno v:
Pediatric Transplantation. 26
The role of angiotensin II type 1 receptor antibodies (AT1R-Ab) in pediatric renal transplantation is unclear. Here, we evaluated pre-transplant AT1R-Ab on transplant outcomes in the first 5 years. Secondary analysis compared pre-transplant AT1R-Ab l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a460b9f37bab877e4e7c8ed4a805b10d
https://doi.org/10.1111/petr.14400
https://doi.org/10.1111/petr.14400
Autor:
Meghan Pearl, Patricia L. Weng, Lucia Chen, Aditi Dokras, Helen Pizzo, Jonathan Garrison, Carrie Butler, Jennifer Zhang, Elaine F Reed, Irene K. Kim, Jua Choi, Mark Haas, Xiaohai Zhang, Ashley Vo, Eileen Tsai Chambers, Robert Ettenger, Stanley Jordan, Dechu Puliyanda
Publikováno v:
Clinical Transplantation. 36
Treatment options for antibody-mediated rejection (AMR) are limited. Recent studies have shown that inhibition of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling can reduce inflammation and slow AMR progression.We report our experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31dd173ec5479f872ed7a288324e7d9d
https://doi.org/10.1111/ctr.14734
https://doi.org/10.1111/ctr.14734
Autor:
Shili Ge, Maggie Chu, Jacqueline Tang, Joseph Kahwaji, Artur Karasyov, Darly Lovato, Ashley Vo, Jua Choi, Stanley C. Jordan, Ruan Zhang, Mieko Toyoda
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(2)
Maintenance with "everolimus + reduced dose tacrolimus" (Ev + TacHLA-sensitized (HS) kidney transplant patients were monitored pre- and post-transplant for viremia (cytomegalovirus (CMV), BK, and Epstein-Barr virus (EBV)) by polymerase chain reaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b4b5f299e4dc6ca78156bb5f058bf9
https://pubmed.ncbi.nlm.nih.gov/35213773
https://pubmed.ncbi.nlm.nih.gov/35213773
Autor:
Ashley A. Vo, Edmund Huang, Noriko Ammerman, Mieko Toyoda, Shili Ge, Mark Haas, Xiaohai Zhang, Alice Peng, Reiad Najjar, Summer Williamson, Catherine Myers, Supreet Sethi, Kathlyn Lim, Jua Choi, Matthew Gillespie, Jacqueline Tang, Stanley C. Jordan
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 22(4)
Alloantibodies are a significant barrier to successful transplantation. While desensitization has emerged, efficacy is limited. Interleukin-6 (IL-6) is an important mediator of inflammation and immune cell activation. Persistent IL-6 production incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9170d2695b9aca5e43e6fcc89d51ae2
https://pubmed.ncbi.nlm.nih.gov/34910841
https://pubmed.ncbi.nlm.nih.gov/34910841
Autor:
Stanley C. Jordan, Supreet Sethi, Reiad Najjar, Noriko Ammerman, Sanjeev Kumar, Kathlyn Lim, Ashley Vo, Edmund Huang, Irene Kim, Jua Choi, Alice Peng
Publikováno v:
Clinical Journal of the American Society of Nephrology. 15:109-116
Background and objectives Delayed graft function is related to ischemia-reperfusion injury and may be complement dependent. We previously reported from a randomized, placebo-controlled trial that treatment with C1 esterase inhibitor was associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ade195bbd602bfe184b0a5b6986db77
https://doi.org/10.2215/cjn.04840419
https://doi.org/10.2215/cjn.04840419
Publikováno v:
Transplantation. 104(8)
Background Antibody-dependent cell-mediated cytotoxicity (ADCC) is an important pathway responsible for antibody-mediated rejection (AMR). Imlifidase (IdeS) cleaves human IgG into F(ab')2 and Fc fragments, potentially inhibiting ADCC. Here we examine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d80382c7966ca603e57ccbb54bf35b24
https://pubmed.ncbi.nlm.nih.gov/32732834
https://pubmed.ncbi.nlm.nih.gov/32732834
Autor:
Stanley C. Jordan, Edmund Huang, Irene Kim, Noriko Ammerman, Jua Choi, Ashley Vo, Gordon D. Wu, Sanjeev Kumar, Mieko Toyoda
Publikováno v:
Transplantation. 104(12)
Interleukin 6 (IL-6) is a cytokine with critical innate and adaptive immunity functions. It's diverse immunologic and physiologic actions include direction of immune cell differentiation, initial response to invading pathogens and ischemic injury, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01231d4a6012ec98cd9ba9fef09fac6c
https://pubmed.ncbi.nlm.nih.gov/32235253
https://pubmed.ncbi.nlm.nih.gov/32235253